Rias Ali MD PLLC · Patient Education
Download PDF Call 727-943-5200
Language
Accessibility
Fibrates Guide

Understanding Fibrates: Fenofibrate and Gemfibrozil

A triglyceride pill family, and why a falling number did not mean a safer heart

Understanding Fibrates: Fenofibrate and Gemfibrozil cover diagram
QR code linking to https://go.riasalimd.com/fibrates-guide
Scan to save this guide

Point your phone camera at the QR code, or visit go.riasalimd.com/fibrates-guide

Written by Rias Ali, MD, FACC, Board-Certified Interventional Cardiologist · 4740 Mile Stretch Drive, Holiday, FL 34690 · Updated November 2026

Online: https://go.riasalimd.com/fibrates-guide

Names & Terms You Will Hear

Plain-language meanings for the terms your care team may use.

TermMeaning
FibratesThe common name for this whole drug family.
Fibric acid derivativesThe chemical family name for fibrates. You may see this on a pharmacy handout.
PPAR-alpha agonistsThe mechanism-based name. It describes how fibrates work: they turn on PPAR-alpha, a switch inside liver cells.
FenofibrateBrand names have included Tricor, Lipofen, Antara, Fenoglide, Lofibra, and Triglide, plus generic versions. Brand availability changes over time; ask your pharmacist which product you have.
Fenofibric acidThe active form your body turns fenofibrate into. Sold on its own as Trilipix or Fibricor.
GemfibrozilBrand name Lopid. Widely available as a generic.
Bezafibrate and ciprofibrateOlder fibrates used in Europe and elsewhere. Neither is sold in the United States.
ClofibrateThe first fibrate, brand name Atromid-S. Withdrawn from the U.S. market after its own outcome trial (see Why It Matters).
PemafibrateBrand name Parmodia. A newer, more selective fibrate-type drug used in Japan. Not approved for use in the United States.
SPPARM-alphaShort for 'selective PPAR-alpha modulator,' the technical name for pemafibrate's drug class.
Triglycerides (TG)A type of fat carried in your blood, and the main target of fibrate therapy. See our separate Triglycerides guide for a full explanation.
HypertriglyceridemiaThe medical term for high triglycerides.
Severe or very severe hypertriglyceridemiaVery high triglycerides, generally 500 mg/dL or higher and especially over 1,000 mg/dL, the range where pancreatitis risk becomes the main concern.
The single most important safety line in this guide: never combine gemfibrozil with a statin. Gemfibrozil blocks how your liver clears statins. Statin levels in your blood climb sharply. So does the risk of serious muscle damage, called rhabdomyolysis. Fenofibrate is the fibrate to use if you also take a statin. It does not share this danger.

What Are Fibrates?

Fibrates activate PPAR-alpha, mostly in the liver. That one switch drives three downstream effects. Together, they lower triglycerides, raise HDL a little, and leave LDL's direction unpredictable. (Schoonjans, Staels, Auwerx 1996.)
Fibrates activate PPAR-alpha, mostly in the liver. That one switch drives three downstream effects. Together, they lower triglycerides, raise HDL a little, and leave LDL's direction unpredictable. (Schoonjans, Staels, Auwerx 1996.)

Why It Matters

Five fibrate-class trials, in order. Early trials, run without background statin therapy, were positive. Later trials added a fibrate on top of modern therapy. There, the benefit shrank, then disappeared. Every figure here is independently verified against the published trial.
Five fibrate-class trials, in order. Early trials, run without background statin therapy, were positive. Later trials added a fibrate on top of modern therapy. There, the benefit shrank, then disappeared. Every figure here is independently verified against the published trial.
The punchline: PROMINENT was the largest, most rigorous fibrate trial ever run. It tested pemafibrate in the exact patients earlier trials pointed to: people with diabetes, high triglycerides, and low HDL. Triglycerides fell 26%. Heart attacks, strokes, and cardiovascular deaths did not fall at all. ApoB, a marker of artery-clogging particles, rose instead of falling. Lowering a triglyceride number is not the same goal as lowering heart risk. Proving one does not prove the other.

Risk Factors

Certain things raise your triglycerides, and with them, the chance you will need a fibrate.

Risk FactorWhy It Increases Risk
Poorly controlled diabetesHigh blood sugar drives the liver to make more triglyceride-rich particles. It also slows how fast they clear from the blood.
Obesity, especially around the bellyExtra fat tissue raises triglyceride production. It also lowers the activity of the enzyme that clears them.
Heavy alcohol useThe liver turns alcohol into triglycerides. Even a few drinks can spike levels in someone prone to high triglycerides.
An underactive thyroid (hypothyroidism)Thyroid hormone helps clear triglycerides from the blood. Too little of it lets levels climb.
Kidney diseaseReduced kidney function changes how the body handles triglyceride-rich particles. It can raise levels.
Certain other medicinesEstrogen pills, tamoxifen, steroids, and some other drugs can raise triglycerides as a side effect. A fibrate may be added on top of these causes, not instead of fixing them.
A family tendency toward high triglyceridesSome families carry genes that make triglycerides run high. Levels can even reach the range where pancreatitis becomes a real risk.

Treatment Options

Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.

The number that actually changes what your care team recommends. Below 200 mg/dL, a fibrate is not indicated. From 200 to 499, statins and lifestyle lead instead. At 500 and above the goal shifts to preventing pancreatitis, and above 1,000 a fibrate is first-line for that. Preventing pancreatitis is a separate goal from protecting your heart.
The number that actually changes what your care team recommends. Below 200 mg/dL, a fibrate is not indicated. From 200 to 499, statins and lifestyle lead instead. At 500 and above the goal shifts to preventing pancreatitis, and above 1,000 a fibrate is first-line for that. Preventing pancreatitis is a separate goal from protecting your heart.

Comparing the Fibrates: Availability, Statin Safety, and Notes

AgentUS AvailabilityCombine With a Statin?Kidney (Renal) NoteOther Notes
Fenofibrate (and fenofibric acid)Yes. Brand and generic; several brand names over the years.Yes. This is the fibrate to use with a statin.Dose lowered or avoided with significant kidney impairment.Usually once daily. Fenofibric acid (Trilipix, Fibricor) is the same active drug.
GemfibrozilYes. Generic only.DO NOT COMBINE WITH A STATIN.Dose adjusted for kidney impairment.Usually twice daily, before meals. Mainly used alone.
PemafibrateNo. Approved in Japan, not the United States.Studied on top of a statin in PROMINENT. No heart-protection benefit was shown even so.Not applicable; not US-marketed.The most rigorously tested fibrate-class drug for heart protection, and the one that most clearly showed none.
Bezafibrate, ciprofibrate, clofibrateNo. Not currently marketed in the United States.Not applicable.Not applicable.Clofibrate (Atromid-S) was the original fibrate; its own trial is why this guide's history section exists.

Tier 1: Normal to Borderline-High (Under 150 to 199 mg/dL)

Tier 2: High (200 to 499 mg/dL)

Tier 3: Very High (500 mg/dL and Above)

Comfort Measures at Home (No Medication Needed)

These lifestyle steps lower triglycerides directly, sometimes enough on their own. Use them alongside any fibrate your doctor prescribes.

Risks, Benefits, and Alternatives

Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.

Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.

OptionRisksBenefitsAlternatives
Starting fenofibrate to prevent pancreatitisGallstones. A reversible rise in creatinine. Muscle aches. Rarely, a liver enzyme rise.The guideline's first choice once triglycerides reach the severe range. It lowers the risk of a dangerous, painful pancreas problem.Very strict diet and alcohol changes. A prescription omega-3 product. Treating a cause such as poorly controlled diabetes.
Adding a fibrate on top of a statin, hoping for extra heart protectionExtra pill burden and cost. A small muscle risk. A serious drug interaction if gemfibrozil is chosen by mistake.Not proven. The large modern trials (FIELD, ACCORD-Lipid, PROMINENT) found no clear benefit. One subgroup showed a possible, unproven signal.Icosapent ethyl, a different triglyceride drug proven in its own trial (REDUCE-IT). Or simply raising the statin dose.
Choosing gemfibrozil over fenofibrate while on a statinA sharply higher risk of serious muscle breakdown (rhabdomyolysis). Gemfibrozil raises statin levels in your blood.None over fenofibrate. Gemfibrozil adds no benefit that fenofibrate does not also give.Fenofibrate. It does not share this dangerous interaction.
Using lifestyle change alone, without a fibrateMay not lower triglycerides enough if levels are very high or genetic. Takes sustained effort.No drug cost, side effects, or interactions. It treats root causes: diet, alcohol, weight, blood sugar.Add a fibrate if triglycerides reach the severe, pancreatitis-risk range despite lifestyle change.

Common Misconceptions

MythReality
My triglycerides came down, so my heart risk came down too.Not always. PROMINENT showed triglycerides fell 26% with pemafibrate. Heart attacks and strokes did not change at all. A lab number improving is not the same as a lower risk, unless a trial has actually proven it.
Fibrates and statins are interchangeable cholesterol pills.They are not. Statins lower LDL. They have decades of proof they prevent heart attacks. Fibrates mainly lower triglycerides. The large modern trials have not shown that adding one to a statin prevents more heart attacks.
All fibrates are the same.Not for safety. Gemfibrozil sharply raises statin levels in your blood. That raises the risk of serious muscle damage. Fenofibrate does not share this problem. That is why it is the fibrate used with a statin.
My creatinine went up, so this drug is damaging my kidneys.Most often, no. Fibrates commonly cause creatinine, a kidney blood test, to rise a little. This is usually just a lab effect, not true kidney damage. It is usually reversible. Your care team still watches it.
It is a cholesterol drug.It is mainly a triglyceride drug. Its effect on LDL cholesterol is smaller. LDL can even rise when triglycerides start very high.
If it does not prevent heart attacks, there is no reason to take it.There is still one clear reason: very high triglycerides. They raise the risk of a painful, dangerous problem called pancreatitis. Preventing that is the main modern reason people take a fibrate.

Possible Complications

Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.

Where / WhatWhat Can Happen
Hepatobiliary: GallstonesFibrates raise the amount of cholesterol dissolved in bile. That can lead to gallstones. This is the same effect that troubled the original fibrate, clofibrate, in the 1970s.
Hepatobiliary: Liver enzyme elevationBlood tests that check the liver, called transaminases, can rise on a fibrate. Your care team checks these with routine blood work.
Musculoskeletal: Muscle pain and, rarely, muscle breakdown (myopathy)Fibrates can cause muscle pain on their own. The risk rises sharply if gemfibrozil is combined with a statin. Fenofibrate does not carry this same added risk.
Renal: A rise in creatinineFibrates commonly nudge the creatinine blood test upward. This is usually a reversible lab effect, not true kidney failure. Your care team still monitors it.
Hematologic: A stronger effect from warfarinFibrates can increase the blood-thinning effect of warfarin. That raises bleeding risk. Your care team may check your levels, called INR, more often and adjust your dose.
Pancreatic and vascular: Uncommon trial signalsIn the FIELD trial, fenofibrate was linked to slightly more reported pancreatitis (0.8% vs 0.5%) and lung blood clots (1.1% vs 0.7%) than placebo. These were uncommon, but worth knowing about.
About that creatinine bump: many patients get scared when a routine blood test shows creatinine rising after starting a fibrate. In most people, this is just a reversible change in the lab number itself. It is not a sign your kidneys are failing. Your care team still checks it. A true drop in kidney function is a reason to adjust or stop the drug. But a small, stable rise is common and expected.

Points to Know

Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.

If you remember nothing else, remember these key points.

When to Call Us — and When to Call 911

Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.

If you are not sure, call. We would rather hear from you twice than miss a real problem.

Office: 727-943-5200

Related Guides From Our Practice

Trusted Resources

Independent, evidence-based pages we recommend for deeper reading.

Sources Used to Build This Guide

Scan to visit RiasAliMD.com
Visit RiasAliMD.com
Scan to save Dr. Rias Ali contact
Save Contact

Read this guide in your language

EspañolSpanishالعربيةArabic中文ChineseFrançaisFrenchDeutschGermanΕλληνικάGreekKreyòl AyisyenHaitian CreoleעבריתHebrewहिन्दीHindiItalianoItalian
日本語Japanese한국어KoreanമലയാളംMalayalamفارسیPersianPolskiPolishPortuguêsPortugueseРусскийRussianTagalogTagalogதமிழ்TamilతెలుగుTeluguTiếng ViệtVietnamese

Automatic translation — not reviewed by a qualified medical translator and it may contain errors. The English version is the official one. For your medicines, symptoms, or an emergency, use the English or Spanish guide or call the office. In an emergency, call 911.